Biodronate 30Mg Inj is a hypocalcemic agent that belongs to the bisphosphonates class. It is mainly used in lowering blood calcium levels and bone metastases/lesions in cancer patients. Besides this, it is also used to treat mild to moderate Paget's disease. Hypercalcemia (increased calcium levels) is a condition in which the calcium level in your blood is elevated due to certain conditions. Paget’s disease is a serious condition of bone that disrupts the replacement of old bone tissue with new bone tissue, resulting in the new bone that is abnormally shaped, weak, and brittle.

Biodronate 30Mg Inj contains Pamidronate as an active ingredient, which belongs to the class of bisphosphonates. It works by inhibiting the osteoclast bone resorption, which causes bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. Thus, it helps retain the normal density of bones and restores bone integrity, bone strength and bone health.

Biodronate 30Mg Inj may cause certain side effects such as injection site reactions, stomach pain, loss of appetite, nausea, vomiting, fever, headache, dizziness, mouth sores, constipation, and cough. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist for a longer period, please consult your doctor. Biodronate 30Mg Inj is a parenteral preparation. A trained healthcare professional will administer it. Hence, do not self-administer.

Biodronate 30Mg Inj should be avoided if you are allergic to it or any other components present in it. Before receiving Biodronate 30Mg Inj, let your doctor know about all your medical conditions, sensitivities, and medications you are using to rule out any interactions. Biodronate 30Mg Inj should be used under caution if you have/had kidney disease, liver problems, bone disorders, musculoskeletal pain, and high blood pressure. Biodronate 30Mg Inj is not recommended for use in pregnant women due to foetal harm, and whether this medicine can be used for breastfeeding mothers is unknown. Hence, inform your doctor if you are pregnant or are breastfeeding before receiving Biodronate 30Mg Inj. This medicine is not recommended for use in children as safety and efficacy have not been established.

Biodronate 30Mg Inj contains Pamidronate as an active ingredient, which belongs to the class of bisphosphonates. It works by inhibiting the osteoclast bone resorption, which causes bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. Thus, it helps retain the normal density of bones and restores bone integrity, strength, and health.

Biodronate 30Mg Inj should be avoided if you are allergic to it or any other components present in it. Before receiving Biodronate 30Mg Inj, let your doctor know about all your medical conditions, sensitivities, and medication history you are using to rule out any interactions. Biodronate 30Mg Inj should be used under caution if you have/had kidney disease, liver problems, bone disorders, musculoskeletal pain, and high blood pressure. Biodronate 30Mg Inj is not recommended for use in pregnant women due to foetal harm, and whether this medicine can be used for breastfeeding mothers is unknown. Hence, inform your doctor if you are pregnant or are breastfeeding before receiving Biodronate 30Mg Inj. This medicine is not recommended for use in children as safety and efficacy have not been established.

• Try to consume calcium and vitamin D in their diet as it helps make stronger bones and avoid everyday osteoporosis dangers.
• Regular exercise like weight-bearing exercises are important for maintaining bone health.
• Calcium is important for making bones strong. Vitamin D is equally important, which helps ensure calcium absorption and retention in bones, so take food high in calcium and vitamins.

• Injection site reactions
• Nausea
• Vomiting
• Dizziness
• Constipation
• Stomach pain
• Loss of appetite
• Headache
• Cough
• Fever
• Mouth sores

• Your doctor may suggest certain blood tests, like serum calcium, CBC, and kidney function tests, to check for any unpleasant effects.
• Bone density scans are used to check bone mineral density (BMD).
• Clinical monitoring of serum electrolyte concentrations may also be advised.

Hypercalcemia: Hypercalcemia is when the calcium level in the blood is higher than normal. Too much calcium in the blood can weaken the bones, create kidney stones, and interfere with working the heart and brain. It is usually a result of overactive parathyroid glands. Symptoms include increased thirst and urination, stomach pain, nausea, bone pain, muscle weakness, confusion and fatigue.

Paget's disease: Paget's disease is a chronic disease of bone that disrupts the replacement of old bone tissue with new bone tissue, resulting in the new bone that is abnormally shaped, weak and brittle. It most commonly occurs in the pelvis, skull, spine, and legs. Symptoms include bone pain, joint pain (especially in the back, hips, and knees), headache, enlargement and bowing of the thighs (femurs) and lower legs (tibias), and enlargement of the skull in the area of the forehead.